Upcoming AACR Meeting Focuses on Recent Advances in Pancreatic Cancer Research
Pancreatic cancer is projected to become the second leading cause of cancer mortality in the United States by 2030....
Pancreatic cancer is projected to become the second leading cause of cancer mortality in the United States by 2030....
When new cells are needed to replace old, worn-out cells in our organs and tissues, the DNA that encodes...
Back for the final push of summer are the editors’ picks from the eight peer-reviewed scientific journals published by...
The AACR Project Genomics Evidence Neoplasia Information Exchange (AACR Project GENIE) is a unique registry that aggregates, harmonizes, and...
Building on advances in technology and analytical tools, real-world data (RWD) sources have attracted increasing interest as means to...
Rare cancers, when taken all together, make up an estimated 20 to 25 percent of all cancers diagnosed. With...
Over the course of AACR Annual Meeting 2019, there were 213 presentations on incredibly exciting clinical trials. This is...
In the past couple of decades, progress against cancer has created a new generation of survivors. Today, more than...
About 80 percent of lung cancers are non-small cell lung cancers (NSCLC), and about 15 to 20 percent of...
“Do you want to have fun?” Richard Pazdur, MD, director of the U.S. Food and Drug Administration (FDA) Oncology...